UPDATE 1-Australia’s Telix Prescribed drugs considers US itemizing

(Provides particulars from paragraph 2)

Jan 5 (Reuters) – Australia’s Telix Prescribed drugs stated on Friday it was planning an preliminary public providing in the USA and itemizing on the Nasdaq.

The corporate, nonetheless, didn’t disclose the variety of American Depositary Shares to be issued or a timeline for the itemizing.

“There may be no assurance as to the incidence, timing, pricing and/or completion of such an providing or itemizing,” the corporate stated.

No last resolution has been made in respect of the Nasdaq itemizing, the corporate added.

Bizarre shares of the Melbourne-based oncology agency, which has a market worth of A$3.07 billion ($2.06 billion), will stay listed on the Australian Securities Trade.

($1 = 1.4921 Australian {dollars}) (Reporting by Archishma Iyer in Bengaluru; Modifying by Sriraj Kalluvila)